Genetics and Family Risk: What to Know if You Have Hypertrophic Cardiomyopathy (HCM)

Genetics and Family Risk: What to Know if You Have Hypertrophic Cardiomyopathy (HCM)

Genetics and Family Risk: What to Know if You Have Hypertrophic Cardiomyopathy (HCM)
Jaime Grajales Benjumea/iStock; Jeniffer Fontan/iStock

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition that can potentially cause serious complications. The condition runs in families, so if you’ve been diagnosed, you may have concerns about how other people in your family may be impacted as well.

Fortunately, screening tools and genetic testing can give your loved ones the information they need, so they can take steps to protect their heart health.

HCM Is an Inherited Condition

HCM is characterized by the thickening and stiffening of the walls of the bottom left chamber of the heart, which makes it harder for the heart to fill with blood and send blood out to the rest of the body.

 It’s caused by a genetic mutation that can be inherited by first-degree relatives, passed from parent to child.

“It’s an autosomal dominant disease, which means it has a 50 percent chance of being passed on to other family members,” says Matthew Martinez, MD, the director of Atlantic Health System Sports Cardiology at Morristown Medical Center in Morristown, New Jersey. “In any patient who has a clinical diagnosis of hypertrophic cardiomyopathy, all first-degree relatives are also at risk.” So when you have HCM, there’s a high likelihood that your children or siblings may have the condition as well.

That said, HCM severity and symptoms can vary significantly from person to person, even those who are related. “Within a family, you can have someone who might need surgery, someone who might be asymptomatic, and someone who might need a heart transplant,” says Dr. Martinez.

HCM Often Goes Undiagnosed

HCM doesn’t always cause symptoms. It’s also common for people with mild symptoms, like shortness of breath while exercising or fatigue, to ignore them or think they’re a result of something else.

“People might think ‘I’m just getting older,’ or ‘I’m not in good shape,’ or ‘I’m tired because my kids are wearing me out,’” says Martinez. “You come up with reasons to not be concerned.”

As a result, up to 85 percent of people with HCM don’t know they have it.

But that can be dangerous, experts warn. “Even in the absence of symptoms, the condition can progress over time, and complications such as abnormal heart rhythms or heart function changes can still occur,” says Diala Steitieh, MD, the director of the hypertrophic cardiomyopathy program at Weill Cornell Medicine in New York City. In rare instances, undiagnosed and unmanaged HCM can even lead to sudden cardiac death.

HCM Screening

When you have HCM, screenings can determine whether other people in your family have the condition as well. “Regular screenings and follow-ups are important, even for individuals who feel completely well,” says Dr. Steitieh.

Screenings, which are noninvasive, typically take place at a cardiologist’s office and are ideally conducted by a cardiologist who specializes in HCM. The cardiologist performs a thorough exam with multiple tests, including:

  • Echocardiogram This ultrasound imaging test shows how well the heart is pumping blood.
  • Electrocardiogram (ECG/EKG) This test uses sensors placed on the skin to measure the heart’s electrical activity. It can detect irregular heart rhythms and heart thickening.
  • Physical Exam and Family History During this exam, a cardiologist can check for irregular heartbeats and learn about HCM in a person’s family.
A cardiologist may opt to order additional tests to learn more about a person’s heart activity and function. These tests can include the use of a Holter monitor to track your heart rhythm while you complete your regular activities, an exercise stress test, and other imaging tests like a cardiac MRI or cardiac CT scan.

 Even if these screening tests reveal that your family member doesn’t have HCM, they should repeat screenings in the future to check to see if anything changes over time.

Screening tests are typically covered by insurance for people with a first-degree relative with HCM.

But check with your insurer to confirm your plan’s details, including whether you need a referral or prior authorization and whether you’re responsible for any copays.

Who Should Get Screened for HCM?

Anyone with a first-degree relative (a parent, sibling, or child) with HCM should be screened for the condition. If a person doesn’t show signs of HCM at the time of their screening, diagnostics should be repeated regularly every 1-3 years for children and adolescents, and every 3-5 years for adults.

Experts like Steitieh and Martinez agree. “We’ve been able to prove that by screening, we make more diagnoses,” says Martinez. And when you know you have HCM, even if you’re asymptomatic, you and your care team can determine the best way to treat it, thereby reducing your risk of serious complications.

There isn’t a consensus on whether second-degree relatives ought to be screened for HCM as well, so talk with your cardiologist if you have questions or concerns.

 “Screening for second-degree relatives, including aunts, uncles, and cousins, may be appropriate in certain situations, particularly when there’s a strong family history, a known genetic mutation, or concerning symptoms,” says Steitieh.

Children and HCM Screening

A child whose parent has HCM has a 50 percent chance of having HCM themselves.

 What’s more, they’re at higher risk for their HCM becoming severe, since the condition tends to worsen over time and worsen more quickly in children. Children and teens with HCM are at especially high risk of complications such as sudden cardiac death, even when they’re asymptomatic.

Fortunately, screening can help doctors catch HCM in kids. Children and teens should be screened for HCM as soon as a first-degree relative is diagnosed, and undergo repeated screenings as needed every 1-3 years.

“A diagnosis leads to treatment, and treatment leads to better outcomes,” says Martinez.

Genetic Testing for HCM

Genetic testing differs from screening, but it can be a valuable tool for some families in which HCM is prevalent.

Genetic testing offers the opportunity for you to find out which of your genes is involved in your HCM. Once you have that information, your family members can undergo genetic testing to see if they also carry that specific gene.

An HCM gene doesn’t automatically cause HCM, but it does mean the carrier is at risk. “Unlike imaging tests, genetic testing can clarify which relatives are truly at risk and need ongoing heart evaluations, and which relatives are unlikely to develop the condition,” says Steitieh. If a person finds out they’re a carrier, they should see a cardiologist for HCM screening to determine whether they have the condition. If someone isn’t a carrier, they may be less likely to develop HCM.

If you or others opt into genetic testing, you’ll first meet with a genetic counselor to weigh the benefits and drawbacks of testing and what to expect when your results come in. If you decide to proceed with testing, you’ll give a blood or saliva sample that’s then sent to a lab. The lab will analyze the sample for HCM variants. From there, you’ll be notified about the results and discuss next steps with your genetic counselor.

The decision to undergo genetic testing is a personal one. Family members don’t need to have genetic testing in order to be screened for HCM. What’s more, not being a carrier doesn’t guarantee a person is safe from HCM.

“We have to understand its limitations, which is mainly that we don’t know every HCM disease-causing gene,” says Steitieh.

The Takeaway

  • Hypertrophic cardiomyopathy (HCM) is a genetic condition; first-degree relatives (parents, siblings, and children) of a diagnosed individual have a 50 percent chance of inheriting the mutation.
  • Because HCM is often asymptomatic or presents with mild symptoms like fatigue and shortness of breath during exercise, an estimated 85 percent of people with the condition remain undiagnosed, which increases the risk of serious complications or sudden cardiac death.
  • Clinical screenings, including echocardiograms, EKGs, and physical exams, are vital for early detection and should be repeated every 1–3 years for children and every 3–5 years for adults who have a family history of the disease.
  • Genetic testing can identify specific gene mutations to determine which family members are truly at risk. It’s a personal choice and has limitations, because not all HCM-causing genes have been discovered.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Hypertrophic Cardiomyopathy. American Heart Association. May 29, 2024.
  2. Bonaventura J et al. Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease? Journal of the American Heart Association. June 10, 2023.
  3. Hypertrophic Cardiomyopathy: A Serious Heart Condition That May Be Hiding in Plain Sight. Heart Failure Society of America.
  4. Smania MA. Hypertrophic Cardiomyopathy Overview: Genetics, Screening, and Treatment. Journal of the American Association of Nurse Practitioners. March 1, 2025.
  5. HCM Family Screening and Genetic Testing: What You Need to Know. American College of Cardiology.
  6. Hypertrophic Cardiomyopathy. Mayo Clinic. February 23, 2024.
  7. Genetic Testing for Hypertrophic Cardiomyopathy. American Heart Association. June 21, 2022.
  8. Mital S. A Pediatric Perspective on the ACC/AHA Hypertrophic Cardiomyopathy Guidelines. American College of Cardiology. April 1, 2021.
  9. Family Screening. Hypertrophic Cardiomyopathy Association.
  10. About Hypertrophic Cardiomyopathy (HCM). Centers for Disease Control and Prevention. September 10, 2025.
  11. Menzies C et al. Rethinking Childhood-Onset Hypertrophic Cardiomyopathy: A Review of Molecular Mechanisms and Unique Therapy Considerations. Journal of Cardiovascular Development and Disease. September 23, 2025.
chung-yoon-bio

Chung Yoon, MD

Medical Reviewer
Chung Yoon, MD, is a noninvasive cardiologist with a passion for diagnosis, prevention, intervention, and treatment of a wide range of heart and cardiovascular disorders. He enjoys clinical decision-making and providing patient care in both hospital and outpatient settings. He excels at analytical and decision-making skills and building connection and trust with patients and their families.
Marygrace Taylor

Marygrace Taylor

Author

Marygrace Taylor is an award-winning freelance health and wellness writer with more than 15 years of experience covering topics including women’s health, nutrition, chronic conditions, and preventive medicine. Her work has appeared in top national outlets like Prevention, Parade, Women’s Health, and O, The Oprah Magazine.

She's also the coauthor of three books: Eat Clean, Stay Lean: The Diet, Prevention Mediterranean Table, and Allergy-Friendly Food for Families. She lives in Philadelphia.